Sector
Life Sciences
Category
Molecular Drugs
About
Mimetogen is a drug development company focused on the development and commercialization of pharmacologically active small molecules that mimic the action of peptides (peptidomimetics) as well as on small peptides that bind specifically to well-validated and novel proprietary targets. Mimetogen is using its platform technology towards the clinical development of its lead compound in glaucoma as well as the continued development of a strong pipeline of novel therapeutic agents across a wide spectrum of diseases.
Mimetogen news
<< back
|
Mimetogen
1000 de La Gauchetiere Street West, Suite 900
Montreal, Quebec, H3B 5H4
Canada
www.mimetogen.com
|
